Literature DB >> 17411377

CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.

Audrey L Kinter1, Robin Horak, Melanie Sion, Lindsey Riggin, Jonathan McNally, Yin Lin, Robert Jackson, Angeline O'shea, Gregg Roby, Colin Kovacs, Mark Connors, Stephen A Migueles, Anthony S Fauci.   

Abstract

HIV infection is characterized by CD4(+) T cell depletion and progressive immune dysfunction; particularly impacted are HIV-specific T cell responses. An important component of immune-mediated control of HIV replication, killing of infected cells, appears to be impaired, in part due to poor cytolytic activity of HIV-specific cytotoxic T cells (CTL). In vitro, several functions of HIV-specific T cells, such as cytokine production, can be enhanced by the depletion of the immunosuppressive CD25(+) FoxP3(+) CD4(+) regulatory (Treg) cell subset. However, the effect of CD25(+) Treg cells on virus-specific cytolytic activity in the context of HIV or any human viral infection has not been investigated. The present study demonstrates that CD25(+) Treg cells isolated from the peripheral blood of HIV-infected subjects significantly suppress HIV Gag-specific cytolytic activity in vitro. In addition, CD25(+) Treg cells suppress effector function (coexpression of TNF-alpha and IFN-gamma) of HIV-specific CD8(+) T cells that proliferate in response to HIV antigen. Finally, the secretion of HIV-inhibitory CC-chemokines by HIV-specific and nonspecific CD8(+) T cells is significantly reduced in the presence of CD25(+) Treg cells. These data suggest that CD25(+) Treg-mediated suppression of the antiviral activity of HIV-specific CD8(+) T cells could impact the ability of HIV-infected individuals to control HIV replication in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17411377     DOI: 10.1089/aid.2006.0162

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  73 in total

Review 1.  Natural regulatory T cells and persistent viral infection.

Authors:  Shuo Li; Eric J Gowans; Claire Chougnet; Magdalena Plebanski; Ulf Dittmer
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

2.  Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Authors:  Julian Schulze Zur Wiesch; Adriana Thomssen; Philip Hartjen; Ilona Tóth; Clara Lehmann; Dirk Meyer-Olson; Kristina Colberg; Sebastian Frerk; Dalia Babikir; Stefan Schmiedel; Olaf Degen; Stefan Mauss; Jürgen Rockstroh; Schlomo Staszewski; Pavel Khaykin; Alexander Strasak; Ansgar W Lohse; Gerd Fätkenheuer; Joachim Hauber; Jan van Lunzen
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  CD4 regulatory T cells augment HIV-1 expression of polarized M1 and M2 monocyte derived macrophages.

Authors:  Tanya O Robinson; Mingce Zhang; Christina Ochsenbauer; Lesley E Smythies; Randall Q Cron
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

4.  Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization.

Authors:  Xianjing Li; Zhuo Wang; Yulian Zou; Ermei Lu; Jingjing Duan; Hongbao Yang; Qijin Wu; Xiaona Zhao; Yun Wang; Linjun You; Ling He; Tao Xi; Yong Yang
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

6.  Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus.

Authors:  N I Rallón; M López; V Soriano; J García-Samaniego; M Romero; P Labarga; P García-Gasco; J González-Lahoz; J M Benito
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

7.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.

Authors:  Nithianandan Selliah; Mingce Zhang; Sara White; Philip Zoltick; Bassel E Sawaya; Terri H Finkel; Randy Q Cron
Journal:  Virology       Date:  2008-10-01       Impact factor: 3.616

9.  Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.

Authors:  Georgina Thorborn; Laura Pomeroy; Heidi Isohanni; Melissa Perry; Barry Peters; Annapurna Vyakarnam
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

10.  Functional impairment of PRRSV-specific peripheral CD3+CD8high cells.

Authors:  Sarah Costers; David J Lefebvre; Bruno Goddeeris; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2009-05-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.